Related MeSH Hierarchy (6)
Diseases [C] » Infections [C01] » Virus Diseases » RNA Virus Infections » Flaviviridae Infections » Hepatitis C » Hepatitis C, Chronic
Diseases [C] » Infections [C01] » Communicable Diseases » Blood-Borne Infections » Hepatitis C » Hepatitis C, Chronic
Diseases [C] » Digestive System Diseases [C06] » Liver Diseases » Hepatitis » Hepatitis, Viral, Human » Hepatitis C » Hepatitis C, Chronic
Diseases [C] » Pathological Conditions, Signs and Symptoms [C23] » Pathologic Processes » Disease Attributes » Chronic Disease » Hepatitis, Chronic » Hepatitis C, Chronic
Diseases [C] » Infections [C01] » Virus Diseases » Hepatitis, Viral, Human » Hepatitis C » Hepatitis C, Chronic
Diseases [C] » Digestive System Diseases [C06] » Liver Diseases » Hepatitis » Hepatitis, Chronic » Hepatitis C, Chronic
Description
INFLAMMATION of the LIVER in humans that is caused by HEPATITIS C VIRUS lasting six months or more. Chronic hepatitis C can lead to LIVER CIRRHOSIS. MeSH
Hierarchy View
Approved Indicated Drugs (19)
Phase 4 Indicated Drugs (34)
Phase 3 Indicated Drugs (31)
Phase 2 Indicated Drugs (65)
Phase 1 Indicated Drugs (54)
Other Experimental Indicated Drugs (12)
Organization Involved with Phase 4 Indications (153)
Ahvaz Jundishapur University of Medical Sciences
American Research Corporation (ARC)
Center For Hepatitis C, Atlanta, GA
Chronic Liver Disease Foundation
Clinical Pharmacology of Miami
Community Research Initiative of New England
Federal University of Rio de Janeiro
Gottfried Wilhelm Leibniz Universität Hannover
Hamadan University of Medical Science
Hannover Clinical Trial Center GmbH
Hospital Federal de Bonsucesso
Icahn School of Medicine at Mount Sinai
King Faisal Specialist Hospital
Medical University of South Carolina
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
National Institutes of Health (NIH)
New York Presbyterian Hospital
Oregon Health and Science University
People's Liberation Army of China
Pontificia Universidad Catolica de Chile
Principal SIMS/Services hospital lahore
Services Institute of Medical Sciences, Pakistan
Sociedad Andaluza de Enfermedades Infecciosas
Taichung Veterans General Hospital
Tropical Diseases Hospital, Ho Chi Minh City
University of Alabama, Birmingham
Organization Involved with Phase 3 Indications (117)
Ascletis Pharmaceuticals Co., Ltd.
Azienda Ospedaliera S Giovanni Battista
Beijing Kawin Technology Share-Holding Co., Ltd.
CIHR Canadian HIV Trials Network
Clinique Medicale L'Actuel, Que
Federal University of Rio Grande do Sul
French National Agency for Research on AIDS and Viral Hepatitis
Institute Of Cardiology & Internal Diseases, Kazakhstan
Kazan State Medical University
Kermanshah University of Medical Sciences
Kirov Military Medical Academy
LLC Medical Company Hepatolog, Samara, Russia
Minnesota Veterans Medical Research and Education Foundation
Nanjing Sanhome Pharmaceutical, Co., Ltd.
National Cancer Institute (NCI)
National Hepatology & Tropical Medicine Research Institute
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute on Drug Abuse (NIDA)
Regional State Healthcare Institution Smolensk Regional Clinical Hospital
Smolensk State Medical Academy
TCM Biotech International Corp.
The University of Texas, Dallas
University of British Columbia
University of California, Irvine
University of Naples Frederico II
V.I. Razumovsky, Healthcare Committee at the Administration of Saratov City Municipal District
Virginia Commonwealth University
Xiamen Amoytop Biotech Co., Ltd.
Organization Involved with Phase 2 Indications (104)
Antipodean Pharmaceuticals, Inc.
Atlanta Gastroenterology Associates
Badalona Hospital Germans Trias i Pujol
Cantonal Hospital of St. Gallen
Cell Therapy And Technology, S.a. De C.v.
Daiwa Pharmaceutical Corporation
Florida Center for Gastroenterology
Mashhad University of Medical Sciences
Nashville Medical Research Institute
National Center for Complementary and Integrative Health (NCCIH)
Office of Dietary Supplements (ODS)
Razi Vaccine and Serum Research Institute
Russian Academy of Medical Sciences
Shanghai Sundise Traditional Chinese Medicine Co., Ltd.
Southern California Research Center
Sunshine Lake Pharma Co., Ltd.
TaiGen Biotechnology Co., Ltd.
Organization Involved with Phase 1 Indications (33)
Organization Involved with Other Experimental Indications (22)
Postgraduate Institute of Medical Education and Research
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
